The long-term outlook for essential thrombocythemia

被引：3
|
作者：
Campbell, PJ [1 ]
Green, AR [1 ]
机构：
[1] Univ Cambridge, Dept Haematol, Cambridge CB2 1TN, England
来源：
MAYO CLINIC PROCEEDINGS | 2006年 / 81卷 / 02期
关键词：
D O I：
10.4065/81.2.157
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：157 / 158
页数：2
相关论文
共 50 条
  • [21] A LONG-TERM CLINICAL-TRIAL OF INTERFERON ALPHA-THERAPY IN ESSENTIAL THROMBOCYTHEMIA
    MIDDELHOFF, G
    BOLL, I
    ANNALS OF HEMATOLOGY, 1992, 64 (05) : 207 - 209
  • [22] Mutations and Long-Term Outcome of 217 Young Patients with Essential Thrombocythemia or Early Primary Myelofibrosis
    Palandri, Francesca
    Polverelli, Nicola
    Latagliata, Roberto
    Tieghi, Alessia
    Ottaviani, Emanuela
    Crugnola, Monica
    Perricone, Margherita
    Martino, Bruno
    Alimena, Giuliana
    Merli, Francesco
    Aversa, Franco
    Catani, Lucia
    Cavo, Michele
    Martinelli, Giovanni
    Vianelli, Nicola
    BLOOD, 2014, 124 (21)
  • [23] Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis
    Palandri, F.
    Latagliata, R.
    Polverelli, N.
    Tieghi, A.
    Crugnola, M.
    Martino, B.
    Perricone, M.
    Breccia, M.
    Ottaviani, E.
    Testoni, N.
    Merli, F.
    Aversa, F.
    Alimena, G.
    Cavo, M.
    Martinelli, G.
    Catani, L.
    Baccarani, M.
    Vianelli, N.
    LEUKEMIA, 2015, 29 (06) : 1344 - 1349
  • [24] Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results
    Verstovsek, Srdan
    Passamonti, Francesco
    Rambaldi, Alessandro
    Barosi, Giovanni
    Rumi, Elisa
    Gattoni, Elisabetta
    Pieri, Lisa
    Zhen, Huiling
    Granier, Muriel
    Assad, Albert
    Cazzola, Mario
    Kantarjian, Hagop M.
    Barbui, Tiziano
    Vannucchi, Alessandro M.
    BLOOD, 2017, 130 (15) : 1768 - 1771
  • [25] A long-term study of essential thrombocythemia (ET) in women under age 50 years.
    Pereira, DL
    Fonseca, R
    Silverstein, MN
    Hoagland, HC
    Tefferi, A
    BLOOD, 1998, 92 (10) : 423A - 423A
  • [26] HYDROXYUREA DOSING VARIATIONS IN 82 PATIENTS WITH LONG-TERM TREATMENT OF ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA
    Jose Maria, Guerra Hernando
    Ivonne Lizett, Astudillo Romero
    Salas Neus, Amer
    Riera Martin, Mascaro
    Lleonart Juan, Bargay
    Garcia Raquel, Del Campo
    Rodriguez Irene, Vazquez
    Serra Antonia, Cladera
    Perez Delia, Gomez
    Bachs Elena, Gonzlez
    Balanzat Ines, Herraez
    HAEMATOLOGICA, 2021, 106 (10) : 257 - 258
  • [27] Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
    Tefferi, Ayalew
    Guglielmelli, Paola
    Larson, Dirk R.
    Finke, Christy
    Wassie, Emnet A.
    Pieri, Lisa
    Gangat, Naseema
    Fjerza, Rajmonda
    Belachew, Alem A.
    Lasho, Terra L.
    Ketterling, Rhett P.
    Hanson, Curtis A.
    Rambaldi, Alessandro
    Finazzi, Guido
    Thiele, Juergen
    Barbui, Tiziano
    Pardanani, Animesh
    Vannucchi, Alessandro M.
    BLOOD, 2014, 124 (16) : 2507 - 2513
  • [28] LONG-TERM AND LOW-DOSE BUSULFAN IS SAFE AND EFFECTIVE IN ELDERLY PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
    Renso, R.
    Aroldi, A.
    Pioltelli, P.
    Gambacorti-Passerini, C.
    Elli, E. M.
    HAEMATOLOGICA, 2017, 102 : 555 - 556
  • [29] Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis
    F Palandri
    R Latagliata
    N Polverelli
    A Tieghi
    M Crugnola
    B Martino
    M Perricone
    M Breccia
    E Ottaviani
    N Testoni
    F Merli
    F Aversa
    G Alimena
    M Cavo
    G Martinelli
    L Catani
    M Baccarani
    N Vianelli
    Leukemia, 2015, 29 : 1344 - 1349
  • [30] SUPERCONDUCTIVITY - THE NEAR AND LONG-TERM OUTLOOK
    CARUANA, CM
    CHEMICAL ENGINEERING PROGRESS, 1988, 84 (05) : 72 - 76
12345